English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Medicine MedTech
愛康醫療三度榮膺北京市科技一等獎 推動髖關節發育不良診療技術革新
Nov 20, 2024 19:35 HKT
爱康医疗三度荣膺北京市科技一等奖 推动髋关节发育不良诊疗技术革新
Nov 20, 2024 19:12 HKT
康哲药业入选2024年度“中国医药上市公司ESG竞争力”系列榜单
Oct 21, 2024 19:15 HKT
China Medical System: First Ruxolitinib Cream's Prescriptions for Vitiligo Issued in the Greater Bay Area
Oct 21, 2024 10:00 HKT
康哲药业:芦可替尼乳膏(白癜风)大湾区首批处方落地
Oct 18, 2024 14:44 HKT
康哲药业:磷酸芦可替尼乳膏(白癜风)中国上市许可申请已获受理
Sep 24, 2024 21:20 HKT
China Medical System: New Drug Application for Vitiligo Indication of Ruxolitinib Phosphate Cream Accepted in China
Sep 24, 2024 21:00 HKT
Taiwan Excellence Pavilion concludes Medical Fair Asia 2024 with Showcase of Cutting-Edge MedTech Innovations
Sep 13, 2024 17:50 HKT
Taiwan Excellence Unveils Pioneering Medtech Innovation at Medical Fair Asia 2024
Sep 05, 2024 23:00 HKT
Avantor Triumphs with Three Awards at Korea Biopharma Excellence Awards 2024
Aug 23, 2024 08:00 HKT
康哲藥業(00867)發佈2024年中期業績:營業額和利潤環比均穩步提升
Aug 16, 2024 16:42 HKT
康哲药业(00867)发布2024年中期业绩:营业额和利润环比均稳步提升
Aug 16, 2024 16:24 HKT
China Medical System (00867) Released its 2024 Interim Results: Steady Increase in Revenue and Profit Compared with 2H 2023
Aug 16, 2024 13:00 HKT
An Asian Company Achieves Breakthrough in the Key Technology of Ac-225 Preparation
Aug 15, 2024 20:00 HKT
康哲药业:甲氨蝶呤注射液增加类风湿关节炎适应症中国NDA获批(更正版)
Aug 06, 2024 23:49 HKT
康哲藥業:甲氨蝶呤注射液增加類風濕關節炎適應症中國NDA獲批
Aug 06, 2024 17:37 HKT
China Medical System: NDA for Additional Rheumatoid Arthritis Indication of Methotrexate Injection Approved in China
Aug 05, 2024 22:00 HKT
China Medical System (867.HK) Reincluded in S&P Global Sustainability Yearbook (China Edition) and Maintained MSCI ESG "AA" Rating
Jul 16, 2024 20:00 HKT
China Medical System Completes Dosing of the First Subject in Phase III Bridging Trial of Ruxolitinib Cream in Atopic Dermatitis in China
Jun 25, 2024 20:00 HKT
China Medical System: Innovative Drug Methylthioninium Chloride Enteric-coated Sustained-release Tablets Approved for Marketing in China
Jun 18, 2024 18:45 HKT
Next >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: